Position Yourself at the Forefront of APAC's Rapidly Accelerating RNA Service Provider Market
파트너십
South Korea is rapidly emerging as a global hub for RNA innovation, with advancements across mRNA synthesis, delivery, and manufacturing set to accelerate the development of next-generation RNA-based therapeutics. As both government investment and industry collaboration intensify, now is a critical time for organizations to enter the market, build strategic partnerships, and position yourself as key player supporting Korea's mRNA journey from R&D through to GMP.
By partnering with the World Advanced Therapeutics Summit South Korea, you can gain access to the region's most engaged decision-makers, creating rare, face-to-face opportunities to build trust, spark partnerships, and unlock new market potential.
With an expected audience of 90+ individuals from across APAC and the West who are seeking the right partner to support efficient scale-up towards global clinical trials, become the go-to partner for those working on the next wave of mRNA technologies for infectious, rare diseases and oncology.
What to Expect?
스폰서십 및 파트너십 기회
Meet New Clients
Expand your client base within the mRNA community by networking face-to-face with large pharma and new biotechs actively seeking solutions to overcome their drug development challenges.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Demonstrate Your Expertise
Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization's future and sharpen its competitive edge.
Key Services & Solutions
주요 관심 분야
Our attendees from mRNA biopharma were looking for service and solution providers with capabilities in the below areas but not limited to:
1
Trailblazing mRNA-LNP Design, Screening & Synthesis Methods
2
Optimizing Analytical Tools for mRNA Release & Nanoparticle Stability
3
Harmonizing Regulatory Documentation Guidance to De-Risk mRNA Drug Approval
4
Pioneering Delivery Solutions & Platform Innovations
5
Improving Pre-Clinical Assays for Potency & Immunogenicity Studies
6
Advancing Clinical Trial Development & Recruitment
7
Utilizing Novel Technologies for mRNA Drug Manufacturing & Scale Up
8
Increasing Marketing Access & Commercialization Planning
Audience Breakdown
참가자 구성
Company Type
Attendee Seniority
Attendees by Location
Attending Companies Include
Get in Touch
팀에게 문의하기
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
William Hobson-Corbett
Partnerships Director
Kieran Crewe
Partnerships Director
Charlotte Hodgson
Partnerships Director